Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts

Traitements anti-angiogéniques dans le cancer colorectal métastatique : peut-on envisager un blocage continu de l’angiogenèse ?

(2015) Marine Jary et al.   BULLETIN DU CANCER

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors

(2014) Enrico P Spugnini et al.   Journal of Translational Medicine

Combining low-dose or metronomic chemotherapy with anticancer vaccines

(2014) Heng Sheng Sow et al.   OncoImmunology

Hypoxia-inducible factor-1 as a therapeutic target in cancer

(2012) Ceen-Ming Tang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice

(2009) Hongchi Jiang et al.   CANCER INVESTIGATION

Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells

(2009) Y.-Q. Xiong et al.   CLINICAL CANCER RESEARCH